To amend the Public Health Service Act to provide for the inclusion of a biological attribution strategy, and an early warning strategy and implementation plan, in the National Health Security Strategy, and for other purposes.
HB4165 amends the Public Health Service Act to require that the National Health Security Strategy include two new planning components: a biological attribution strategy and an early warning strategy and implementation plan. The biological attribution strategy is intended to improve federal coordination on identifying the source, cause, or origin of biological hazards and pathogens with pandemic potential. It directs the Secretary of Health and Human Services to describe agency responsibilities, define when attribution determinations should be made, set milestones and timelines, and plan for new technologies, including diagnostic, sequencing, and safe-collection capabilities.
The bill also requires an early warning strategy and implementation plan for biological, chemical, and radiological threats. That plan would focus on earlier detection of emerging threats, understanding recurring threats, adapting technologies to new hazards such as synthetic drugs and fentanyl, and expanding detection through sources like wastewater, airports, and transportation hubs. It also emphasizes rapid deployment of technologies during public health events and coordination with state and local public health entities, private-sector and academic partners, and relevant federal agencies, including the CDC, ASPR, and the Office of the Director of National Intelligence.
If enacted, the bill would amend the Public Health Service Act and expand the National Health Security Strategy by adding new federal preparedness and detection planning requirements. It would not create a new standalone program, but it would require HHS to coordinate across agencies and with nonfederal partners on biological attribution and early warning capabilities. The practical effect would be to formalize federal planning around pathogen source attribution, cross-border and foreign threat awareness, and broader biosurveillance and threat-detection infrastructure.
No committee transcript or vote data is available, so the bill’s sentiment must be inferred from its text and sponsorship. The measure appears broadly supportive of public health preparedness, interagency coordination, and modernization of detection tools. Its bipartisan introduction by Representatives Crenshaw and Swalwell suggests an effort to frame the bill as a security and public health measure rather than a partisan proposal.
The main potential points of contention are likely to be the scope of federal coordination, the use of intelligence and national security considerations in biological attribution, and the extent of surveillance or data collection implied by expanded early warning systems. Some stakeholders may support the bill’s emphasis on diagnostics, sequencing, and rapid deployment, while others may raise concerns about privacy, duplication of existing federal programs, or the costs and feasibility of implementing new technologies at scale. The bill also touches on sensitive areas such as foreign and cross-border threats, which could prompt debate over agency roles and oversight.